Anal. Method Environ. Chem. J. 3 (3) (2020) 5-17
Research Article, Issue 3
Analytical Methods in Environmental Chemistry Journal
Journal home page: www.amecj.com/ir
AMECJ
Speciation of selenium (IV, VI) in urine and serum of thyroid
patients by ultrasound-assisted dispersive liquid-liquid
microextraction
Elham Mosafayian Jahromya and Negar Motakef Kazemi a,*
a Department of Medical Nanotechnology, Faculty of Advanced Sciences and Technology, Tehran Medical Sciences,
Islamic Azad University, Tehran, Iran
ABSTRACT
In-vitro speciation of inorganic selenium (SeIV and SeVI) in serum
blood and urine of hyperthyroidism and hypothyroidism patients
based on isopropyl 2-[(isopropoxycarbothiolyl) disulfanyl] ethane
thioate (IICDET) as a complexing agent were studied by ultrasound-
assisted dispersive liquid-liquid bio-microextraction procedure (USA-
DLLMBE). In rst stage, 100 μL (≈0.1 g) of hydrophobic ionic liquid
of [C8MIM][PF6] mixed with IICDET ligand and 100 μL of acetone.
Then, the mixture injected to 10 mL of human samples at pH=4. After
shacking, the Se (IV) ions were complexed by IICDET and extracted
to IL at pH=4 (R-S: …Se). The IL phase was separated from sample
by centrifuging and inorganic selenium (Se IV) in remained samples
was determined by electro thermal atomic absorption spectrometry
(ET-AAS) after back extraction of Se (IV). As speciation, the Se (VI)
reduced to Se (IV) in acidic pH (HCl, 130OC) and the total Se(T-
Se) was obtained at pH=4. Therefore, the Se (VI) was calculated
by difference of T-Se and Se (IV). After optimized conditions, the
enrichment factor (EF), Linear range and limit of detection (LOD)
for inorganic Se (IV) were obtained 20.1, 0.75- 20 μg L-1 and 0.18
μg L-1 in serum and urine samples respectively. The results showed
us, the concentration of selenium was decreased in thyroid patients
as compared to healthy peoples. The validation of methodology was
achieved by certied reference material (CRM) and ICP-MS.
Keywords:
Selenium,
Inorganic speciation,
Serum and urine,
Isopropyl [(IsopropoxyCarbothiolyl)
Disulfanyl] Ethane Thioate,
Ultrasound-assisted dispersive liquid-
liquid bio-microextraction,
ARTICLE INFO:
Received 22 May 2020
Revised form 17 Jul 2020
Accepted 11 Aug 2020
Available online 26 Sep 2020
*Corresponding Author: Negar Motakef Kazemi
Email: negar.motakef@gmail.com
https://doi.org/10.24200/amecj.v3.i03.109
------------------------
1. Introduction
Selenium is an essential trace element in humans.
The soluble selenium compounds can be easily
absorbed through the lungs and the gastrointestinal
tract. Selenium is mainly excreted in human urine
[1]. When the exposure is very high it can also be
excreted in exhaled air as dimethylselenide vapor
(DMSe). Normal selenium concentrations in serum
and urine are dependent on daily intake, which may
vary considerably in different parts of the world but
are usually below 15 μg per 100 mL-1 and 25 μg
g-1 creatinine, respectively [2-5]. The concentration
of selenium in urine is mainly a reection of recent
exposure. The relationship between the intensity of
exposure and selenium concentration in urine has not
been established yet. It seems that the concentration
in plasma (or serum) and urine mainly reects to
short-term exposure, whereas the selenium content
of erythrocytes reects more long-term exposure
6Anal. Method Environ. Chem. J. 3 (3) (2020) 5-17
[6]. Measuring selenium in blood or urine gives
some information on selenium status. Currently it is
more often used to detect a deciency rather than an
overexposure. Since the available data concerning the
health risk of long-term exposure to selenium and the
relationship between potential health risk and levels
in biological media are too limited. So, the biological
threshold value for Se wasn’t reported [7]. The thyroid
is the organ with the highest selenium content per gram
of tissue because it expresses specic selenoproteins.
The value of selenium supplementation in
autoimmune thyroid disorders has been emphasized.
Most authors attribute the effect of supplementation
on the immune system to the regulation of the
production of reactive oxygen species and their
metabolites [8-10]. The mechanism and role of
selenium in inammation, immunity and hepatocytes
was reported [11, 12] In patients with Hashimoto’s
disease and in pregnant women with anti-TPO
antibodies, selenium supplementation decreases anti-
thyroid antibody levels and improves the ultrasound
structure of the thyroid gland [13]. Although clinical
applications still need to be dened for Hashimoto’s
disease, they are very interesting for pregnant
women given that supplementation signicantly
decreases the percentage of postpartum thyroiditis
and denitive hypothyroidism. In Graves’ disease,
selenium supplementation results in euthyroidism
being achieved more rapidly and appears to have a
benecial effect on mild inammatory orbitopathy
[14]. A risk of diabetes has been reported following
long-term selenium supplementation, but few data
are available on the side effects associated with such
supplementation and further studies are required.
One of the diseases that affect the thyroid gland is
subclinical hypothyroidism, which is characterized
by elevated serum levels of thyroid-stimulating
hormone (TSH) at a concentration recommended
for prohormone thyroxine (T4) and active hormone
triiodothyronine (T3). The decompensated levels of
thyroid hormones may contribute to atherosclerotic
events and an increase in cardiovascular-related
mortality [15]. Also, observational longitudinal
studies have shown an inverse association between
selenium exposure and risk of some cancer types
but still to be conrmed [16]. It is estimated that
subclinical hypothyroidism affects 3–8% of the
general population and is more common in women
than in men. In Brazil, an epidemiological study
in elderly reported that prevalence of subclinical
hypothyroidism was 6.5%. The thyroid gland
contains high levels of selenium (Se) and expresses
a variety of selenoproteins that are involved in
protection of oxidative stress and metabolism of
thyroid hormones (TH) [17]. Selenium deciency
impairs regular synthesis of selenoproteins and
adequate TH metabolism. Therefore selenium species
in serum and urine must be evaluated and determined
by favorite techniques. The different methods such
as, ame atomic absorption spectrometry [18],
electrothermal atomic absorption spectrometry [19],
liquid chromatography and liquid chromatography
inductively coupled plasma mass spectrometry (LC
and LC-ICP- MS) [20-22] and high-performance
liquid chromatography coupled to hydride generation
atomic uorescence spectrometry [23,24] were used
for Se determination in different human and water
samples. A sample preparation is required to extract
metals ions in different biological samples. The sample
preparation such as microextraction techniques [25],
suspended dispersive solid phase microextraction
[26], ultrasonic assisted dispersive liquid-liquid
microextraction method [27] and ultrasound assisted-
ionic liquid-solid phase microextraction [28] were used
for extraction metals in human samples. In this study,
the mixture of hydrophobic ionic liquid of [C8MIM]
[PF6], IICDET ligand and acetone was used for
selenium speciation /extraction based on ultrasound-
assisted dispersive liquid-liquid bio-microextraction
procedure (USA-DLLMBE) and determined by ET-
AAS. The Se (IV) ions were complexed by IICDET
and extracted to IL at pH=4. Then speciation of Se
was obtained by total determination of selenium.
Validation methodology was conrmed by spiking of
standard samples and ICP-MS.
2. Experimental
2.1. Instrument and Reagents
The electrothermal atomic absorption
spectrophotometer (ET-AAS, GBC 932 plus, Australia)
7
Speciation of selenium (IV, VI) in human urine and serum Elham Mosafayian Jahromy et al
equipped with a graphite furnace (Pal GF3000) were
used for the validation and determination of selenium
(Se) in samples (Wavelength 349.9 nm; slit 0.2 nm;
current 10 mA). The working range as peak area and
height was obtained 15- 400 μg L-1 and 15-210 μg L-1,
respectively. The linear range was achieved for peak
area of 0.3 Abs for sample injection. Based on the
manual book of ET-AAS, the Se determination was
achieved by injecting 20 µL of sample to graphite tube
with auto-sampler in three steps of drying, ashing,
and atomization for Se. The ICP-MS (Perkin Elmer,
USA) as ultra-trace analysis with high sensitivity was
used for determining of Se(IV) and Se(VI) in human
blood and water samples (1100 W; 15 L min-1; 1.5 sec
per mass; auxiliary gas 1.12 L min-1). The Metrohm
pH meter based on the glass electrode was used for
measuring pH in serum, urine and blood samples
(E-744, Switzerland). The vortex mixer were used
for shaking of human samples based on 300 rpm
speeds and centrifuged by Falcon accessory by 4000
rpm speeds (Thermo, USA). An ultrasonic bath was
used for blood and urine samples with heat controller
between 30- 120oC (Thomas, USA). The standard
solution of Se (VI, VI) was purchased from Merck
CO. (Germany) with a concentration of 1000 mg L-1
in 1 % HNO3. The different concentration of Selenium
was prepared by dilution of deionized water (DW)
and ultrapure water was purchased from Millipore
Company. The 1-Hexyl-3-methylimidazolium
hexauorophosphate as hydrophobic ionic liquid was
purchased from Sigma Aldrich ([HMIM][PF6], CAS
N: 304680-35). Isopropyl 2-[(isopropoxycarbothioyl)
disulfanyl] ethane thioate was synthesized and puried
by Azad university laboratories (IICDET; (CH3)4
(CO)2 S4). The acetate (CH3COOH/ CH3COONa) and
phosphate buffer was used to adjust the pH between
2.8–6.2 and 6.2–8.2, respectively. The analytical grade
of reagents such as polyoxyethylene octyl phenyl
ether (TX-100) as the anti-sticking agent, HNO3, HCl,
acetone, and ethanol were purchased from Sigma
Aldrich, Germany.
2.2. Preparation of human samples
All glass or PCV tubes were cleaned with a 1.0
mol L-1 HNO3 solution for at least one day and
then washed for ten times with ultrapure water. As
low concentrations of Se(IV) and Se(VI) in human
serum, blood and urine samples, the cations or
anions contamination at any stage of sample
preparation, saving and analytical processes can be
affected on the results accuracy. Heparin was used
as anticoagulants for human blood samples into
Eppendorf (5 mL) tubes and kept at -20OC for two
weeks. Each blood samples were prepared by 10
μL of pure heparin (free Se) to blood sample. The
serum, blood and urine samples were collected from
hypothyroidism patients (50) and healthy peoples
(50) with aged between 25 - 60 years, Tehran
(IRAN). In this study, the world medical association
declaration of Helsinki (WMADH) based on
guiding physicians in human body research was
obtained by the Ethical Committee of Azad
University (E.C.: R.IAU.PS.REC.1399.106). The
human samples were prepared based on WMADH
law and protected the life and health of the human.
2.3. Synthesis of IICDET ligand
The 2.0×10-3 mol of potassium O-isopropyl
(ditiocarbomate) was dissolved in 20 mL of DW
and cooled in an ice bath for 10 minutes. The
2.0×10-3 mol of iodine solution and potassium
iodide as drop wise was added to 20 ml of DW. After
stirring of mixture for 1h, the aqueous phase was
extracted with CH2Cl2 and washed with 30 mL of
aqueous Na2S2O3(10%) and DW. The organic phase
was dried and evaporated with powder anhydrous
calcium chloride Ca Cl2 (99.99%; CAS Number:
10043-52-4). The purification was obtained by
recrystallization in hexane. A pale yellowish crystal
of isopropyl 2-[(isopropoxycarbothiolyl) disulfanyl]
ethane thioate with a yield of 95% was achieved. The
structure and isopropyl 2-[(isopropoxycarbothiolyl)
disulfanyl] ethane thioate were confirmed by NMR
spectroscopic methods (Fig. 1). 1H NMR (CDCl3). δ
(ppm): 1.43 (d, 12H, CH3), 5.63 (m, 2H, CH).
13C NMR (CDCl3). δ (ppm): 22.2, 80.6, 207.1.
IR (KBr). νmax (cm−1): 2979.8 (s), 2869.9 (w),
1463.9 (s), 1442.7 (s), 1373.0 (s), 1271.1 (s, b),
1145.6 (s), 1082.2 (s), 1048.0 (s, b) 898.8 (s), 796. 5
(s), 690. 5 (m).
8Anal. Method Environ. Chem. J. 3 (3) (2020) 5-17
Fig.1. NMR spectroscopic for isopropyl 2-[(isopropoxycarbothiolyl) disulfanyl] ethane thioate
2.4. Extraction Procedure
The Se (IV) based on IICDET ligand was extracted
by ultrasound-assisted dispersive liquid-liquid bio-
microextraction procedure (USA-DLLMBE). By
procedure, 100 μL (≈0.1 g) of hydrophobic ionic
liquid of [C8MIM][PF6] mixed with 0.35×10-6 mol
L-1 of IICDET solution and 100 μL of acetone at
pH of 4. The mixture based on Triton X-100, an
emulsier and anti-sticking agent was injected to 5
mL of blood, serum and urine samples which was
diluted with 5 mL of DW. For optimizing, 1.0 μg
L-1 and 20 μg L-1 of standard solution of Se (IV) as
LLOQ and ULOQ was used instead of the blood
and serum samples. After shacking, the Se (IV)
ions were complexed by IICDET and extracted
to IL at pH=4 (R-S: …Se). By centrifuging (3
min), the IL phase was separated from sample and
inorganic selenium (Se IV) was back- extracted
from IL phase in basic pH (0.25 mL of 1.0 mol
L-1 NaOH). Finally, the remained samples was
determined by electro thermal atomic absorption
spectrometry (ET-AAS). the Se (VI) reduced to Se
(IV) in acidic pH (HCl, 130OC) and the total Se(T-
Se) was obtained at pH=4. Therefore, the Se (VI)
was calculated by difference of T-Se and Se (IV)
amount (Fig.2).
3. Results and Discussion
The human blood, serum and urine samples based
on IICDET was used for selenium speciation with
high accuracy by USA-DLLMBE procedure.
The results showed us, the mean concentrations
of Se (IV and VI) in human biological samples in
hypothyroidism patients (50) were signicantly
higher than the healthy peoples (50). As linear
range of selenium between 0.75-20 μg L-1, the
human samples can be diluted before using by
proposed procedure. Based on results, the mean
concentration of total selenium in urine and serum
of hypothyroidism patients was obtained 11.8 μg
g-1 creatinine and 52.6 μg L-1, respectively which
was less than 25 μg g-1 creatinine for urine samples
and 150 μg L-1 for serum samples as TLVs in
standard references.
9
Speciation of selenium (IV, VI) in human urine and serum Elham Mosafayian Jahromy et al
3.1. Effect of ETAAS
The effect of pyrolysis temperature on the
absorbance of Se was studied up to 1000 ºC. The
maximum absorbance was achieved within a range
of 600–800 ºC. Therefore, 700 ºC was selected as
the working pyrolysis temperature for selenium by
nickel nitrate as modier at concentration of 0.05 to
0.1% Ni. In addition, a drying as a 25 s was chosen
for water evaporation, and a long ramp time of 40
s was chosen as it allowed gradual elimination of
trace ionic liquid solution in liquid phase (350 ºC)
and avoided Se loss in pyrolysis temperature. The
effect of atomization temperature on chromium
signal was studied within the range of 2000–2500
ºC, and the maximum signal was obtained at
approx. 2400 ºC. Cleaning time and temperature
were ordered at 2 s and 2500 ºC, respectively, and
argon ow rate was 350 mL min-1
3.2. Optimization of pH
The sample pH for extraction Se(IV) ions based
on IICDET ligand was studied and optimized in
different pH ranges between 2-11 for 0.75μg L-1
as a lower limit of quantication (LLOQ) and 20
μg L-1 selenium as upper limit of quantication
(ULOQ). The complexation Se with sulfur of
IICDET ligand was strongly depended on the pH
of serum, blood and urine samples and caused to
increase the recovery of extraction by ligand. Based
on experimental results, the extraction efciency
of Se(IV) ions was perfectly achieved at pH =3.5-
4.5. Therefore, the USA-DLLMBE procedure
was used to speciation of selenium at pH=4 by
IICDET ligand. The mechanism of Se extraction
was obtained based on the complex formation of
IICDET ligand between Se(IV) ions and sulfur
covalence bonding of IICDET at optimized pH.
The sulfur groups can be deprotonated (SH-) at pH
range of 3.5-8 and pH=4 was used as favorite pH
for extraction of Se(IV) from human biological
samples which was shown in Figure 3. As hydroxyl
form of Se(OH)4 in above pH (more than 6), the
extraction capacity of Se(IV) in basic pH may be
attributed to the afnities of OH groups.
Fig. 2. Separation of selenium (IV) by ultrasound-assisted dispersive liquid-liquid bio-microextraction
procedure (USA-DLLMBE)
10 Anal. Method Environ. Chem. J. 3 (3) (2020) 5-17
3.3. Optimization of IICDET ligand
The concentration of IICDET ligand as important
parameters must be studied and optimized by
USA-DLLMBE procedure. For optimizing, the
concentration of 0.1×10-6-1.0 ×10-6 mol L-1 of
IICDET ligand was used for evaluation. Due
to results, the more concentration of 0.33×10-6
mol L-1 of IICDET, has no effect on recoveries.
So, the concentration of 0.35×10-6 mol L-1
of IICDET was selected as optimum ligand
concentration for high extraction efficiency.
The signal remained constant from 0.35×10-6
mol L-1 up to at least 1.0 ×10-6 mol L-1 IICDET
for 0.75μg L-1 Se as a LLOQ range. Therefore
0.35×10-6 mol L-1 of IICDET concentration
was used for further works. As 20 μg L-1 of Se
as a ULOQ range, the signal remained constant
from 0.4×10-6 mol L-1 up to at least 1.0×10-6
mol L-1 and 0.4×10-6 mol L-1 was selected
as an optimized IICDET concentration.
By adjusting pH, the best performance of
the Se extraction was achieved between
0.3-0.4 μmol L-1 (Fig. 4).
3.4. Optimization of volume and ionic liquid
amount
The sample volume as main parameters for Se
extraction based on IICDET ligand and must
be optimized at pH=4. So, the different volume
of sample urine, blood and serum from 1-20
mL was used for extraction of Se ions by USA-
DLLMBE procedure as 0.75 μg L-1 and 20 μg L-1
of selenium (IV). Perfect extraction more than 95%
was achieved by sample volume of 1 - 10 mL.
By increasing of sample volumes, the extraction
efciency was reduced. On the other hand, in
high sample volumes, the partially solubilized the
ionic liquid phase was increased and decreased
accuracy and precision of results. So, a sample
volume of 5 mL was selected as optimum volume
for Se(IV) extraction based on ICDET ligand by
USA-DLLMBE procedure (Fig. 5). Furthermore,
the amount of ionic liquid effected on extraction
recovery of Se in serum, blood, urine samples.
Therefore, the different amount of ([C8MIM][PF6]
as hydrophobic ionic liquid was studied from
the range of 0.05–0.35 g. Quantitative extraction
was observed at higher than 0.08 g. So, 0.1 g of
Fig.3. The effect of pH on Extraction Se(IV) based on IICDET ligand by USA-DLLMBE procedure
11
Speciation of selenium (IV, VI) in human urine and serum Elham Mosafayian Jahromy et al
Fig. 4. The effect of IICDET ligand on Extraction Se(IV) by USA-DLLMBE procedure
Fig. 5. The effect of sample volume on Extraction Se(IV) by USA-DLLMBE procedure
12 Anal. Method Environ. Chem. J. 3 (3) (2020) 5-17
[C8MIM][PF6] was chosen as optimum mass for Se
extraction in 10 mL of samples at pH=4 (Fig. 6). The
results showed, the amounts of IL have changes a
little mass in different samples. The amounts of IL
for serum, blood and urine samples were obtained
0.09 g, 0.1 g and 0.07 g, respectively.
3.5. Optimization of Eluent
The ionic liquids cannot apply directly by
ETAAS as a viscose solution with high ash point
temperature. So, the se ions were back-extracted
from [C8MIM][PF6] by different eluents such as a
mineral acidic/basic solution. By changing pH, the
complexation of Se-ligand leads to dissociation and
Se ions release into the aqueous phase. Therefore,
the varying concentration of mineral reagents such
as HCl, HNO3, H2SO4, KOH and NaOH from 0.5─3
mol L-1 were used for Se back-extraction from IL
by elution processes (Fig. 7). Based on results,
1.0 mol L-1 of NaOH at 25OC can be back-extracted
Se (IV) from the IL phase). By procedure, 0.25 mL
of 1.0 mol L-1 of NaOH was added and shacked
for I minute at 25 OC. Finally, Se(IV) the remain
solution determining by ET-AAS after dilution
with DW up to 0.5 mL.
3.6. Effect of ultrasound and matrix
By procedure, the different ultrasound times was
studied for selenium extraction in urine, blood
and serum samples from 30 to 300 seconds. The
results showed us, the extraction efciency of Se
improved by increasing the ultra-sonication time
and then the relative response increased. Based
on results, the maximum extraction was shown at
132 seconds and then remained constant. So, 2.2
minutes was selected as optimum time as ligand
complexation (IICDET). Many techniques such as
ETAAS have low sensitivity to metal interference
ions. Therefore, the most interference ions can be
occurred during the pre-concentration or extraction
processes which was effected on accuracy of
results. So, the important metals based on potential
interfering ions for selenium determination were
studied and optimized by procedure. 10 mL sample
containing 20 μg L-1 of Se and 1–4 mg L-1 different
concentration of matrix ions was used. The tolerate
amounts of each ion were tested and results showed
the absorbance alteration of interfering metals
Fig. 6. The effect of amount of ionic liquid on Extraction Se(IV) based on IICDET ligand by
USA-DLLMBE procedure
13
Speciation of selenium (IV, VI) in human urine and serum Elham Mosafayian Jahromy et al
were less than 5%. So, the interfering metals don’t
effected on extraction Se in optimized conditions
(Table 1).
3.7. Analytical features
Analytical gures of merit were evaluated by
USA-DLLMBE procedure for 10 mL of standard
aqueous solutions, serum, urine and blood samples
at pH=4 (Table 2). After preconcentration steps,
the calibration curve was linear from 0.75 – 20 μg
L-1 as a lower limit of quantication (LLOQ) and
upper limit of quantication (ULOQ). Detection
limits (LOD) and precision (RSD %) was evaluated
for selenium extraction by proposed ligand.
The LOD were calculated as the concentration
providing an analytical signal three times higher
than the background noise. The LOD was obtained
186 ng L-1 and 174 ng L-1 for 10 mL of human
and standard samples, respectively (MLOD=180
ng L-1). As precision (RSD %), it was calculated
from ten individual standards. The RSD (%) of
Se (IV) in different concentrations of 0.75, 1.0
5.0, 10, and 20 µg L-1 were obtained 3.8, 3.2, 2.7,
2.6 and 2.45, respectively (MRSD% =2.95). The
enrichment factor (EF), calculated as the ratio of
the concentration of Se after preconcentration to
that prior preconcentration based on curve tting
calibration rule. The EF of 21.2 and 18.9 for human
and standard samples, respectively (M PF=20.1).
3.8. Validation of Results
The selenium was extracted and determined
in human samples based on IICDET ligand
with USA-DLLMBE procedure for 10 mL of
hypothyroidism patients (50) and healthy peoples
(50) with aged between 25 - 60 years (Table 3). The
mean concentration of Se(IV) more than Se(VI)
in human samples and the mean concentration
of Se(IV) and Se(VI) in hypothyroidism patients
lower than healthy peoples. The coloration analysis
(r) of total Se(IV and VI) in hypothyroidism
patients and healthy peoples were less than 0.19
in blood samples. The spiked urine, serum and
blood were used to demonstrate the reliability of
the method for determination of Se(IV) and Se(VI)
in hypothyroidism patients by USA-DLLMBE
procedure (Table 4). The recovery of spiked
samples showed a satisfactorily results with the
Fig. 7. The effect of different eluents on Extraction Se(VI) based on IICDET ligand by USA-DLLMBE procedure
14 Anal. Method Environ. Chem. J. 3 (3) (2020) 5-17
Blood, Serum (I)
Mean ratio
(CI /C Se(IV))Recovery (%)
Se(IV) Se(IV)
Al3+ , Cr3+ 550 96.8
Zn2+, Cu2+, Ni2+, Co2+, Pb2+ 750 - 850 97.6
I-, Br-, F-, Cl-1250 98.9
Na+, K+, Ca2+, Mg2+ 1100 97.7
CO3
2-, PO4
3-, NH4
+950 99.3
Mn2+, As3+ 150 - 250 98.1 - 97.5
Cd2+ 200 98.4
Hg2+ 45 97.3
Urine (I)
Mean ratio
(C I /C Se(IV) )Recovery (%)
Se(IV) Se(IV)
Cl-, NO3
-1200 98.2
Na+, K+1200 98.6
Ca2+, Mg2+ 1000 98.0
Zn2+, Cu2+ 700 97.5
CO3
2-, PO4
3-, NH4
+900 96.9
Hg2+ 50 97.4
Pb2+ 800 98.3
Ni2+, Co2+ 700 97.2
Cd2+ 150 98.5
Mn2+ 100 96.6
Table 1. The effect of interferences ions on extraction of Se(IV) in human samples
by USA-DLLMBE procedure
Features value
Working pH 4.0
Concentration of IICDET 0.35×10-6 mol L-1
Sample volume of Blood, Serum, Urine (mL) 10 .0
Volume of sample injection 20 μL
Linear range (Peak Area)
Linear range (Peak Height)
Mean RSD %, n=10
0.75-20 μg L-1
0.75-10.4 μg L-1
2.95
LOD for human sample 0.187 μg L-1
LOD for standard sample 0.174 μg L-1
Enrichment factor for human blood or serum 21.2
Enrichment factor for standard 18.9
Volume and concentration of NaOH 0.25 mL,1M
Shaking/Centrifuging time 2.2 min, 3.0 min
Correlation coefcient R2 = 0.9997
Table 2. The analytical features for selenium determination
by USA-DLLMBE procedure
15
Speciation of selenium (IV, VI) in human urine and serum Elham Mosafayian Jahromy et al
ability of procedure for determination of Se(IV) and
Se(VI) in hypothyroidism patients. Furthermore,
the real blood, serum and urine samples were
analyzed with ICP-MS and used as a CRM by
USA-DLLMBE procedure. The results showed,
the favorite efciency and reliability of proposed
method for determination and speciation of Se(IV)
and Se(VI) in hypothyroidism patients (Table 5).
4. Conclusions
A simple and efcient method based on
IICDET ligand was used for the speciation and
determination of trace amount of Se(IV) and
Se(VI) in hypothyroidism patients by USA-
DLLMBE procedure coupled to ET-AAS. The main
parameters such as sample volume, pH and ligand
amount were optimized. This procedure introduced
a sensitive, efcient and low cost method for
speciation and separation of the Se(IV) and Se(VI)
in human biological samples. The performance
of USA-DLLMBE procedure for quantication
extraction of Se(IV) and Se(VI) in blood, urine
and serum samples was satisfactory. The favorite
LOD, LOQ and RSD% achieved 0.18, 0.75 and
2.95, respectively and are comparable to previous
reported methods. Based on results, the selenium
concentration in thyroid patients was decreased
as compared to healthy peoples. The method was
validated by certied reference material (CRM)
and ICP-MS analysis in real samples.
Sample Patients (n=50) Healthy peoples (n=50) Patients /healthy
Se(IV) Se(VI) Se(IV) Se(VI) r P value
Serum 77.9 ± 11.9 16.8 ± 4.8 130.7 ± 21.7 21.8 ± 4.3 0.202 <0.001
Urine 14.5 ± 3.7 2.7 ± 0.9 22.7 ± 7.8 3.6 ± 0.8 0.187 <0.001
Whole Blood 81.8 ± 13.8 17.4 ± 5.6 122.4 ± 18.6 34.5 ± 6.6 0.194 <0.001
*Correlations are based on Pearson coefcients (r). Statistical signicance will be observed if P < 0.05
Mean of three determinations of samples ± standard deviation (P = 0.95, n =10)
Table 3. Speciation and determination of Se(IV) and Se(VI) in serum, blood and urine samples based on IICDET
ligand by USA-DLLMBE procedure (Serum and blood: µgL-1, Urine: µg g-1)
Sample
Added *Found (μg L-1) * ICP-Ms Recovery (%)
Se(IV) Se(VI) Se(IV) Se(VI) T-Se T-Se Se(IV) Se(VI) T-Se
Blood
----- ----- 67.5 ± 3.3 12.8± 0.6 80.3 ± 4.2 79.2 ± 2.7 ---- ---- ----
50 ----- 115.3 ± 5.6 12.6 ± 0.5 127.6 ± 6.1 129.3 ± 3.5 95.6 ----- 94.6
----- 10 67.3 ± 3.4 22.7 ± 1.1 90.0 ± 4.7 88.8 ± 2.9 ----- 99.0 97.0
Serum
----- ----- 81.6 ± 3.8 17.5 ± 0.8 99.1 ± 5.1 100.3 ± 3.4 ----- ----- ----
100 ----- 180.2 ± 8.5 17.2 ± 0.7 197.4 ± 9.3 195.6 ± 5.8 98.6 ----- 98.3
----- 20 82.2 ± 4.2 37.2 ± 1.8 119.4 ± 5.5 120.5 ± 3.6 ----- 98.5 101.5
Urine
----- ----- 12.6 ± 0.6 3.8 ± 0.2 16.4 ± 0.8 15.8 ± 0.3 ----- ----- -----
10 ----- 22.4 ± 1.2 3.7 ± 0.2 26.1±1.3 26.5 ± 0.5 98.0 ----- 97.0
----- 5 12.7 ± 0.6 8.6 ± 0.4 21. 3 ± 1.1 20. 8 ± 0.6 ----- 96.0 98.0
*Mean of three determinations ± standard deviation (P= 0.95, n=5)
All blood and serum samples diluted with DW (1: 10)
Table 4. Analytical results of Se(IV), Se(VI) and T-Se determination in serum, blood and urine
samples with USA-DLLMBE procedure and ICP-MS (μg L-1)
16 Anal. Method Environ. Chem. J. 3 (3) (2020) 5-17
5. Acknowledgment
The authors wish to thank from Department of Medical
Nanotechnology, Faculty of Advanced Sciences and
Technology, Tehran Medical Sciences, Islamic Azad
University, (project NS: 960250673). Approval
was obtained from Islamic Azad University, Tehran
Medical Sciences Ethical Committee (Ethical Code:
R.IAU.PS.REC.1399.106).
6. References
[1] G. Bjørklund, J. Aaseth, A.V. Skalny, J.
Suliburska, M.G. Skalnaya, A.A. Nikonorov,
Interactions of iron with manganese, zinc,
chromium, and selenium as related to
prophylaxis and treatment of iron deciency, J.
Trace Elem. Med. Biol., 41(2017) 41–53.
[2] M. Kucharzewski, J. Braziewicz, U.
Majewska, S. Góźdź, Concentration of
selenium in the whole blood and the thyroid
tissue of patients with various thyroid
diseases, Biol. Trace Elem. Res., 88 (2002)
25–30.
[3] M.K. Gürgöze, A. Olçücü, A.D. Aygün, E.
Taskin, M. Kiliç, Serum and hair levels of
zinc, selenium, iron, and copper in children
with iron-deciency anemia, Biol. Trace
Elem. Res., 111 (2006) 23-29.
[4] W. Chin-Thin, C. Wei-Tun, P. Tzu-Ming, W.
Ren-Tse, Blood concentrations of selenium,
zinc, iron, copper and calcium in patients
with hepatocellular carcinoma, Clin. Chem.
Lab. Med., 40 (2002) 1118-1122.
[5] A.K. Baltaci, R. Mogulkoc, M. Belviranli,
Serum levels of calcium, selenium,
magnesium, phosphorus, chromium, copper
and iron--their relation to zinc in rats with
induced hypothyroidism, Acta Clin. Croat.,
52 (2013) 151- 156.
[6] G.F. Combs, Biomarkers of selenium
status, Nutrients., 7 (2015) 2209–36
[7] P.P. Felix, E.L. Ander, Urine selenium
concentration is a useful biomarker for
assessing population level selenium status,
Environ. Int., 134 (2020) 105218.
[8] D.L. Hateld, P.A. Tsuji, B.A. Carlson, V.N.
Gladyshev, Selenium and selenocysteine:
Roles in cancer, health, and development,
Trends Biochem. Sci., 39 (2014) 112–20.
[9] W. Yang, A.M. Diamond, Selenium-binding
protein as a tumor suppressor and a prognostic
indicator of clinical outcome, Biomark
Res., 1 (2013) 15.
[10] Y. Wang, W. Fang, Y. Huang, F. Hu, Q.
Ying, W. Yang, B. Xiong, Reduction of
selenium-binding protein 1 sensitizes cancer
cells to selenite via elevating extracellular
glutathione: a novel mechanism of cancer-
specic cytotoxicity of selenite, Free Radic.
Biol. Med., 79 (2015) 186-196.
[11] S. Misra, R.W. Kwong, S. Niyogi, Transport
of selenium across the plasma membrane
of primary hepatocytes and enterocytes of
rainbow trout, J. Exp. Biol., 215 (2012)
1491–501.
[12] Z. Huang, A.H. Rose, P.R. Hoffmann,
The role of selenium in inammation and
immunity: from molecular mechanisms to
therapeutic opportunities, Antioxid Redox
Sample Certied (μg L-1)Added (μg L-1)*Found (μg L-1) Recovery (%)
CRM1598a 13.44 ± 0.58 10 23.22 ± 1.14 97.8
S-ICP-MS 15.56 ± 0.46 10 25.13 ± 1.23 95.7
* Mean of three determinations ± standard deviation (P= 0.95, n=5)
All blood and serum samples diluted with DW (1: 10)
CRM1598a selenium in animal serum
S-ICP-MS: Human serum analyses with ICP-MS
Table 5. Validation of methodology for determination selenium based on certied reference
material (CRM) by USA-DLLMBE procedure
17
Speciation of selenium (IV, VI) in human urine and serum Elham Mosafayian Jahromy et al
Sign. 16 (2012) 705-743
[13] N. Manevska, S. Stojanoski, T. Makazlieva,
Selenium treatment effect in auto-immune
hashimoto thyroiditis in macedonian population,
J. Endocrinol. Metabol., 9 (2019) 22-28.
[14] M. Leo, L. Bartalena., G. Rotondo Dottore,
Effects of selenium on short-term control
of hyperthyroidism due to Graves’ disease
treated wif methimazole: results of a
randomized clinical trial, J. Endocrinol.
Invest., 40 (2017) 281–287.
[15] G. Ira Martin, R. James, Sowers thyroid and
the heart, Am. J. Med., 127 (2014) 691–698.
[16] M. Outzen, A. Tjonneland, E.H. Larsen, S.
Friis, S.B. Larsen, J. Christensen, Selenium
status and risk of prostate cancer in a Danish
population, Brit. J. Nutr., 115 (2016) 1669‐77.
[17] A. Dalia, T. Loh, A. Sazili, M. Jahromi, A.
Samsudin, The effect of dietary bacterial
organic selenium on growth performance,
antioxidant capacity, and selenoproteins gene
expression in broiler chickens, BMC Vet.
Res., 13 (2017). http://doi:10.1186/s12917-
017-1159-4.
[18] S.S. Najim, Determination of some trace
elements in breast cancer serum by atomic
absorption spectroscopy, Int. J. Chem., 9
(2017) 1-6.
[19] M. Krawczyk-Coda, Determination of
selenium in food samples by high-resolution
continuum source atomic absorption
spectrometry after preconcentration on
halloysite nanotubes using ultrasound-assisted
dispersive micro solid-phase extraction, Food
Anal. Meth., 12 (2019) 128-135.
[20] A. Terol, F. Ardini, A. Basso, M. Grotti,
Determination of selenium urinary
metabolites by high temperature liquid
chromatography-inductively coupled plasma
mass spectrometry, J. Chromatogr., 1380
(2015) 112–119.
[21] K. Pyrzynska, A. Sentkowska, Liquid
chromatographic analysis of selenium species
in plant materials, TrAC, Trend Anal. Chem.,
111 (2019) 128–138.
[22] C.K Su, W.C. Chen, 3D-printed, TiO2 NP-
incorporated minicolumn coupled with
ICP-MS for speciation of inorganic arsenic
and selenium in high-salt-content samples,
Microchim. Acta., 185 (2018) 1–8.
[23] M. Pettine, T.J. McDonald, M. Sohn, G.A.K.
Anquandah, R. Zboril, V.K.A Sharma, Critical
review of selenium analysis in natural water
samples, Trends Environ. Anal., 5 (2015)
1–7.
[24] T. Hu, L.P. Liu, S.Z. Chen, W.L. Wu, G.G.
Xiang, Y.B. Guo, Determination of selenium
species in cordyceps militaris by high-
performance liquid chromatography coupled
to hydride generation atomic uorescence
spectrometry, Anal. Lett., 51 (2018) 2316-
2330.
[25] A.S.A. Ibrahim, R. Al-Farawati, U. Hawas,Y,
Shaban, Recent microextraction techniques
for determination and chemical speciation of
selenium, Open Chem., 15 (2017) 103–122.
[26] L. Nyaba, J.M. Matong, K.M. Dimpe,
P.N. Nomngongo, Speciation of inorganic
selenium in environmental samples
after suspended dispersive solid phase
microextraction combined with inductively
coupled plasma spectrometric determination,
Talanta., 159 (2016) 174–180.
[27] A.H. Panhwar; M. Tuzen, T.G. Kazi,
Ultrasonic assisted dispersive liquid-liquid
microextraction method based on deep eutectic
solvent for speciation, preconcentration and
determination of selenium species (IV) and
(VI) in water and food samples, Talanta, 175
(2017) 352–358.
[28] N. Motakef Kazemi, A novel sorbent based
on metal–organic framework for mercury
separation from human serum samples by
ultrasound assisted- ionic liquid-solid phase
microextraction, Anal. Methods Environ.
Chem. J., 2 (2019) 67-78.
